227 related articles for article (PubMed ID: 26743380)
1. Gene-based analysis of the fibroblast growth factor receptor signaling pathway in relation to breast cancer in African American women: the AMBER consortium.
Ruiz-Narváez EA; Haddad SA; Lunetta KL; Yao S; Bensen JT; Sucheston-Campbell LE; Hong CC; Haiman CA; Olshan AF; Ambrosone CB; Palmer JR
Breast Cancer Res Treat; 2016 Jan; 155(2):355-63. PubMed ID: 26743380
[TBL] [Abstract][Full Text] [Related]
2. Hormone-related pathways and risk of breast cancer subtypes in African American women.
Haddad SA; Lunetta KL; Ruiz-Narváez EA; Bensen JT; Hong CC; Sucheston-Campbell LE; Yao S; Bandera EV; Rosenberg L; Haiman CA; Troester MA; Ambrosone CB; Palmer JR
Breast Cancer Res Treat; 2015 Nov; 154(1):145-54. PubMed ID: 26458823
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in the insulin, insulin-like growth factor, growth hormone, and leptin pathways in relation to breast cancer in African-American women: the AMBER consortium.
Ruiz-Narváez EA; Lunetta KL; Hong CC; Haddad S; Yao S; Cheng TD; Bensen JT; Bandera EV; Haiman CA; Troester MA; Ambrosone CB; Rosenberg L; Palmer JR
NPJ Breast Cancer; 2016; 2():16034-. PubMed ID: 27942580
[TBL] [Abstract][Full Text] [Related]
4. Associations of polymorphisms in the genes of FGFR2, FGF1, and RBFOX2 with breast cancer risk by estrogen/progesterone receptor status.
Cen YL; Qi ML; Li HG; Su Y; Chen LJ; Lin Y; Chen WQ; Xie XM; Tang LY; Ren ZF
Mol Carcinog; 2013 Nov; 52 Suppl 1():E52-9. PubMed ID: 23143756
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants in the mTOR pathway and breast cancer risk in African American women.
Cheng TD; Ambrosone CB; Hong CC; Lunetta KL; Liu S; Hu Q; Yao S; Sucheston-Campbell L; Bandera EV; Ruiz-Narváez EA; Haddad S; Troester MA; Haiman CA; Bensen JT; Olshan AF; Palmer JR; Rosenberg L
Carcinogenesis; 2016 Jan; 37(1):49-55. PubMed ID: 26577839
[TBL] [Abstract][Full Text] [Related]
6. Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry.
Quan L; Gong Z; Yao S; Bandera EV; Zirpoli G; Hwang H; Roberts M; Ciupak G; Davis W; Sucheston L; Pawlish K; Bovbjerg DH; Jandorf L; Cabasag C; Coignet JG; Ambrosone CB; Hong CC
Int J Cancer; 2014 Mar; 134(6):1408-21. PubMed ID: 23996684
[TBL] [Abstract][Full Text] [Related]
7. Genetic variations in vitamin D-related pathways and breast cancer risk in African American women in the AMBER consortium.
Yao S; Haddad SA; Hu Q; Liu S; Lunetta KL; Ruiz-Narvaez EA; Hong CC; Zhu Q; Sucheston-Campbell L; Cheng TY; Bensen JT; Johnson CS; Trump DL; Haiman CA; Olshan AF; Palmer JR; Ambrosone CB
Int J Cancer; 2016 May; 138(9):2118-26. PubMed ID: 26650177
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in the Hippo pathway and breast cancer risk in women of African ancestry.
Wang S; Huo D; Ogundiran TO; Ojengbede O; Zheng W; Nathanson KL; Nemesure B; Ambs S; Olopade OI; Zheng Y
Mol Carcinog; 2018 Oct; 57(10):1311-1318. PubMed ID: 29873413
[TBL] [Abstract][Full Text] [Related]
9. Genetic susceptibility loci for subtypes of breast cancer in an African American population.
Palmer JR; Ruiz-Narvaez EA; Rotimi CN; Cupples LA; Cozier YC; Adams-Campbell LL; Rosenberg L
Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):127-34. PubMed ID: 23136140
[TBL] [Abstract][Full Text] [Related]
10. An exome-wide analysis of low frequency and rare variants in relation to risk of breast cancer in African American Women: the AMBER Consortium.
Haddad SA; Ruiz-Narváez EA; Haiman CA; Sucheston-Campbell LE; Bensen JT; Zhu Q; Liu S; Yao S; Bandera EV; Rosenberg L; Olshan AF; Ambrosone CB; Palmer JR; Lunetta KL
Carcinogenesis; 2016 Sep; 37(9):870-877. PubMed ID: 27267999
[TBL] [Abstract][Full Text] [Related]
11. Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium.
Hong CC; Sucheston-Campbell LE; Liu S; Hu Q; Yao S; Lunetta KL; Haddad SA; Ruiz-Narváez EA; Bensen JT; Cheng TD; Bandera EV; Rosenberg LA; Haiman CA; Lee K; Evans SS; Abrams SI; Repasky EA; Olshan AF; Palmer JR; Ambrosone CB
Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):321-330. PubMed ID: 29339359
[No Abstract] [Full Text] [Related]
12. Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women.
Rebbeck TR; DeMichele A; Tran TV; Panossian S; Bunin GR; Troxel AB; Strom BL
Carcinogenesis; 2009 Feb; 30(2):269-74. PubMed ID: 19028704
[TBL] [Abstract][Full Text] [Related]
13. Variants of estrogen-related genes and breast cancer risk in European and African American women.
Quan L; Hong CC; Zirpoli G; Roberts MR; Khoury T; Sucheston-Campbell LE; Bovbjerg DH; Jandorf L; Pawlish K; Ciupak G; Davis W; Bandera EV; Ambrosone CB; Yao S
Endocr Relat Cancer; 2014; 21(6):853-64. PubMed ID: 25228414
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women.
Liang J; Chen P; Hu Z; Zhou X; Chen L; Li M; Wang Y; Tang J; Wang H; Shen H
Carcinogenesis; 2008 Dec; 29(12):2341-6. PubMed ID: 18845558
[TBL] [Abstract][Full Text] [Related]
15. Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study.
Slattery ML; John EM; Stern MC; Herrick J; Lundgreen A; Giuliano AR; Hines L; Baumgartner KB; Torres-Mejia G; Wolff RK
Breast Cancer Res Treat; 2013 Aug; 140(3):587-601. PubMed ID: 23912956
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer.
Huo D; Feng Y; Haddad S; Zheng Y; Yao S; Han YJ; Ogundiran TO; Adebamowo C; Ojengbede O; Falusi AG; Zheng W; Blot W; Cai Q; Signorello L; John EM; Bernstein L; Hu JJ; Ziegler RG; Nyante S; Bandera EV; Ingles SA; Press MF; Deming SL; Rodriguez-Gil JL; Nathanson KL; Domchek SM; Rebbeck TR; Ruiz-Narváez EA; Sucheston-Campbell LE; Bensen JT; Simon MS; Hennis A; Nemesure B; Leske MC; Ambs S; Chen LS; Qian F; Gamazon ER; Lunetta KL; Cox NJ; Chanock SJ; Kolonel LN; Olshan AF; Ambrosone CB; Olopade OI; Palmer JR; Haiman CA
Hum Mol Genet; 2016 Nov; 25(21):4835-4846. PubMed ID: 28171663
[TBL] [Abstract][Full Text] [Related]
17. A collaborative study of the etiology of breast cancer subtypes in African American women: the AMBER consortium.
Palmer JR; Ambrosone CB; Olshan AF
Cancer Causes Control; 2014 Mar; 25(3):309-19. PubMed ID: 24343304
[TBL] [Abstract][Full Text] [Related]
18. mTOR pathway candidate genes and obesity interaction on breast cancer risk in black women from the Women's Circle of Health Study.
Ilozumba MN; Yaghjyan L; Datta S; Zhao J; Hong CC; Lunetta KL; Zirpoli G; Bandera EV; Palmer JR; Yao S; Ambrosone CB; Cheng TD
Cancer Causes Control; 2023 May; 34(5):431-447. PubMed ID: 36790512
[TBL] [Abstract][Full Text] [Related]
19. FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.
Agarwal D; Pineda S; Michailidou K; Herranz J; Pita G; Moreno LT; Alonso MR; Dennis J; Wang Q; Bolla MK; Meyer KB; Menéndez-Rodríguez P; Hardisson D; Mendiola M; González-Neira A; Lindblom A; Margolin S; Swerdlow A; Ashworth A; Orr N; Jones M; Matsuo K; Ito H; Iwata H; Kondo N; ; ; Hartman M; Hui M; Lim WY; Iau PT; Sawyer E; Tomlinson I; Kerin M; Miller N; Kang D; Choi J-; Park SK; Noh D-; Hopper JL; Schmidt DF; Makalic E; Southey MC; Teo SH; Yip CH; Sivanandan K; Tay W-; Brauch H; Brüning T; Hamann U; ; Dunning AM; Shah M; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Schmidt MK; Broeks A; Rosenberg EH; van't Veer LJ; Fasching PA; Renner SP; Ekici AB; Beckmann MW; Shen C-; Hsiung C-; Yu J-; Hou M-; Blot W; Cai Q; Wu AH; Tseng C-; Van Den Berg D; Stram DO; Cox A; Brock IW; Reed MW; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Zheng W; Deming-Halverson S; Shrubsole MJ; Long J; Shu X-; Lu W; Gao Y-; Zhang B; Radice P; Peterlongo P; Manoukian S; Mariette F; Sangrajrang S; McKay J; Couch FJ; Toland AE; ; Yannoukakos D; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Marme F; Burwinkel B; Guénel P; Truong T; Sanchez M; Mulot C; Bojesen SE; Nordestgaard BG; Flyer H; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Mannermaa A; Kataja V; Kosma V-; Hartikainen JM; Lambrechts D; Yesilyurt BT; Floris G; Leunen K; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Wang X; Olson JE; Vachon C; Purrington K; Giles GG; Severi G; Baglietto L; Haiman CA; Henderson BE; Schumacher F; Marchand LL; Simard J; Dumont M; Goldberg MS; Labréche F; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Devilee P; Tollenaar RA; Seynaeve C; García-Closas M; Chanock SJ; Lissowska J; Figueroa JD; Czene K; Eriksson M; Humphreys K; Darabi H; Hooning MJ; Kriege M; Collée JM; Tilanus-Linthorst M; Li J; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Bogdanova N; Dörk T; Hall P; Chenevix-Trench G; Easton DF; Pharroah PD; Arias-Perez JI; Zamora P; Benítez J; Milne RL
Br J Cancer; 2014 Feb; 110(4):1088-100. PubMed ID: 24548884
[TBL] [Abstract][Full Text] [Related]
20. Association of polymorphisms in intron 2 of FGFR2 and breast cancer risk in Сhinese women.
Pan Z; Bao Y; Zheng X; Cao W; Cheng W; Xu X
Tsitol Genet; 2016; 50(5):59-64. PubMed ID: 30480917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
